Drug Type Biological products |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Elasmogen Ltd.Startup |
Active Organization Elasmogen Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | GB | Elasmogen Ltd.Startup | 16 Jun 2024 |
Inflammatory Bowel Diseases | Discovery | GB | Elasmogen Ltd.Startup | 01 Dec 2024 |